{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:32:34Z","timestamp":1792089154362,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Scleroderma Research Foundation (US)"},{"DOI":"10.13039\/100015629","name":"Jerome L. Greene Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015629","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Donald B. and Dorothy L. Stabler Foundation"},{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)","award":["P30AR053503"],"award-info":[{"award-number":["P30AR053503"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-0993-2","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T11:38:46Z","timestamp":1462361926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma"],"prefix":"10.1186","volume":"18","author":[{"given":"Andrea","family":"Fava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaello","family":"Cimbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick M.","family":"Wigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Boin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,4]]},"reference":[{"key":"993_CR1","first-page":"1366","volume-title":"Kelley\u2019s Textbook of Rheumatology","author":"F Boin","year":"2012","unstructured":"Boin F, Wigley FM, et al. Clinical Features and Treatment of Scleroderma. In: Kelley\u2019s Textbook of Rheumatology. 9th ed. Philadelphia: Elsevier; 2012. p. 1366\u2013403.","edition":"9"},{"key":"993_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","volume":"166","author":"RJ Prescott","year":"1992","unstructured":"Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol. 1992;166:255\u201363.","journal-title":"J Pathol"},{"key":"993_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11926-007-0012-3","volume":"9","author":"F Boin","year":"2007","unstructured":"Boin F, Rosen A. Autoimmunity in systemic sclerosis: current concepts. Curr Rheumatol Rep. 2007;9:165\u201372.","journal-title":"Curr Rheumatol Rep"},{"key":"993_CR4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","volume":"49","author":"JD Reveille","year":"2003","unstructured":"Reveille JD, Solomon DH, American College of Rheumatology Ad Hoc Committee of Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum. 2003;49:399\u2013412.","journal-title":"Arthritis Rheum"},{"key":"993_CR5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis. 2007;66:754\u201363.","journal-title":"Ann Rheum Dis"},{"key":"993_CR6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","volume":"6","author":"SI Nihtyanova","year":"2010","unstructured":"Nihtyanova SI, Denton CP. Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol. 2010;6:112\u20136.","journal-title":"Nat Rev Rheumatol"},{"key":"993_CR7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/annrheumdis-2012-202849","volume":"73","author":"TR Cottrell","year":"2014","unstructured":"Cottrell TR, Wise RA, Wigley FM, Boin F. The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis. Ann Rheum Dis. 2014;73:1060\u20136.","journal-title":"Ann Rheum Dis"},{"key":"993_CR8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/1529-0131(200005)43:5<1074::AID-ANR18>3.0.CO;2-E","volume":"43","author":"M Kuwana","year":"2000","unstructured":"Kuwana M, Kaburaki J, Mimori T, Kawakami Y, Tojo T. Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis. Arthritis Rheum. 2000;43:1074\u201384.","journal-title":"Arthritis Rheum"},{"key":"993_CR9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/rheumatology\/40.10.1135","volume":"40","author":"S Sato","year":"2001","unstructured":"Sato S, Hamaguchi Y, Hasegawa M, Takehara K. Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis. Rheumatology (Oxford). 2001;40:1135\u201340.","journal-title":"Rheumatology (Oxford)"},{"key":"993_CR10","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/art.10977","volume":"48","author":"PQ Hu","year":"2003","unstructured":"Hu PQ, Fertig N, Medsger TA, Wright TM. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum. 2003;48:1363\u201373.","journal-title":"Arthritis Rheum"},{"key":"993_CR11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/1529-0131(199904)42:3<465::AID-ANR11>3.0.CO;2-Y","volume":"42","author":"M Kuwana","year":"1999","unstructured":"Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA, Wright TM. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum. 1999;42:465\u201374.","journal-title":"Arthritis Rheum"},{"key":"993_CR12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1172\/JCI118071","volume":"96","author":"M Kuwana","year":"1995","unstructured":"Kuwana M, Medsger TA, Wright TM. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest. 1995;96:586\u201396.","journal-title":"J Clin Invest"},{"key":"993_CR13","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/1529-0131(200107)44:7<1654::AID-ART288>3.0.CO;2-O","volume":"44","author":"M Kuwana","year":"2001","unstructured":"Kuwana M, Feghali CA, Medsger TA, Wright TM. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis. Arthritis Rheum. 2001;44:1654\u20139.","journal-title":"Arthritis Rheum"},{"key":"993_CR14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/ard.2003.008037","volume":"63","author":"S Veeraraghavan","year":"2004","unstructured":"Veeraraghavan S, Renzoni EA, Jeal H, Jones M, Hammer J, Wells AU, et al. Mapping of the immunodominant T cell epitopes of the protein topoisomerase I. Ann Rheum Dis. 2004;63:982\u20137.","journal-title":"Ann Rheum Dis"},{"key":"993_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1196\/annals.1358.016","volume":"1062","author":"F Boin","year":"2005","unstructured":"Boin F, Wigley FM, Schneck JP, Oelke M, Rosen A. Evaluation of topoisomerase-1-specific CD8+ T-cell response in systemic sclerosis. Ann N Y Acad Sci. 2005;1062:137\u201345.","journal-title":"Ann N Y Acad Sci"},{"key":"993_CR16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaut.2006.03.004","volume":"26","author":"PQ Hu","year":"2006","unstructured":"Hu PQ, Oppenheim JJ, Medsger TA, Wright TM. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I. J Autoimmun. 2006;26:258\u201367.","journal-title":"J Autoimmun"},{"key":"993_CR17","doi-asserted-by":"crossref","unstructured":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581\u201390.","DOI":"10.1002\/art.1780230510"},{"key":"993_CR18","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281\u20135.","journal-title":"J Rheumatol"},{"key":"993_CR19","doi-asserted-by":"crossref","unstructured":"Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 1991;144:1202\u201318.","DOI":"10.1164\/ajrccm\/144.5.1202"},{"key":"993_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179\u201387.","journal-title":"Am J Respir Crit Care Med"},{"key":"993_CR21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1164\/arrd.1987.135.4.805","volume":"135","author":"RJ Knudson","year":"1987","unstructured":"Knudson RJ, Kaltenborn WT, Knudson DE, Burrows B. The single-breath carbon monoxide diffusing capacity. Reference equations derived from a healthy nonsmoking population and effects of hematocrit. Am Rev Respir Dis. 1987;135:805\u201311.","journal-title":"Am Rev Respir Dis"},{"key":"993_CR22","first-page":"2159","volume":"26","author":"TA Medsger","year":"1999","unstructured":"Medsger TA, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26:2159\u201367.","journal-title":"J Rheumatol"},{"key":"993_CR23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/ard.2009.111906","volume":"69","author":"FC Arnett","year":"2010","unstructured":"Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis. 2010;69:822\u20137.","journal-title":"Ann Rheum Dis"},{"key":"993_CR24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8:639\u201346.","journal-title":"Nat Immunol"},{"key":"993_CR25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","volume":"118","author":"JP Ioannidis","year":"2005","unstructured":"Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger Jr TA, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005;118:2\u201310.","journal-title":"Am J Med"},{"key":"993_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MD.0b013e31829be125","volume":"92","author":"AC Gelber","year":"2013","unstructured":"Gelber AC, Manno RL, Shah AA, Woods A, Le EN, Boin F, et al. Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature. Medicine (Baltimore). 2013;92:191\u2013205.","journal-title":"Medicine (Baltimore)"},{"key":"993_CR27","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.1780370904","volume":"37","author":"VD Steen","year":"1994","unstructured":"Steen VD, Lanz Jr JK, Conte C, Owens GR, Medsger Jr TA. Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. Arthritis Rheum. 1994;37:1290\u20136.","journal-title":"Arthritis Rheum"},{"key":"993_CR28","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/art.20265","volume":"50","author":"PJ Clements","year":"2004","unstructured":"Clements PJ, Goldin JG, Kleerup EC, Furst DE, Elashoff RM, Tashkin DP, et al. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis. Arthritis Rheum. 2004;50:1909\u201317.","journal-title":"Arthritis Rheum"},{"key":"993_CR29","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/art.22696","volume":"56","author":"NS Goh","year":"2007","unstructured":"Goh NS, Veeraraghavan S, Desai SR, Cramer D, Hansell DM, Denton CP, et al. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum. 2007;56:2005\u201312.","journal-title":"Arthritis Rheum"},{"key":"993_CR30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1097-0320(19961215)26:4<305::AID-CYTO11>3.0.CO;2-V","volume":"26","author":"M Mardiney","year":"1996","unstructured":"Mardiney M, Brown MR, Fleisher TA. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals. Cytometry. 1996;26:305\u201310.","journal-title":"Cytometry"},{"key":"993_CR31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nm1293","volume":"11","author":"PK Chattopadhyay","year":"2005","unstructured":"Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med. 2005;11:1113\u20137.","journal-title":"Nat Med"},{"key":"993_CR32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.158.1.485","volume":"158","author":"M Kuwana","year":"1997","unstructured":"Kuwana M, Medsger TA, Wright TM. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope. J Immunol. 1997;158:485\u201391.","journal-title":"J Immunol"},{"key":"993_CR33","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","volume":"181","author":"I Kryczek","year":"2008","unstructured":"Kryczek I, Bruce AT, Gudjonsson JE, et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol. 2008;181:4733\u201341.","journal-title":"J Immunol"},{"key":"993_CR34","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","volume":"42","author":"M Chabaud","year":"1999","unstructured":"Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999;42:963\u201370.","journal-title":"Arthritis Rheum"},{"key":"993_CR35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","volume":"172","author":"JS Tzartos","year":"2008","unstructured":"Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol. 2008;172:146\u201355.","journal-title":"Am J Pathol"},{"key":"993_CR36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","volume":"207","author":"MS Wilson","year":"2010","unstructured":"Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, Cheever AW, et al. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med. 2010;207:535\u201352.","journal-title":"J Exp Med"},{"key":"993_CR37","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.4049\/jimmunol.1004081","volume":"187","author":"S Mi","year":"2011","unstructured":"Mi S, Li Z, Yang HZ, Liu H, Wang JP, Ma YG, et al. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Immunol. 2011;187:3003\u201314.","journal-title":"J Immunol"},{"key":"993_CR38","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/art.30539","volume":"63","author":"A Yoshizaki","year":"2011","unstructured":"Yoshizaki A, Yanaba K, Ogawa A, Asano Y, Kadono T, Sato S. Immunization with DNA topoisomerase I and Freund\u2019s complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling. Arthritis Rheum. 2011;63:3575\u201385.","journal-title":"Arthritis Rheum"},{"key":"993_CR39","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","volume":"183","author":"F Fossiez","year":"1996","unstructured":"Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183:2593\u2013603.","journal-title":"J Exp Med"},{"key":"993_CR40","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","volume":"65","author":"ME Truchetet","year":"2013","unstructured":"Truchetet ME, Brembilla NC, Montanari E, Lonati P, Raschi E, Zeni S, et al. Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement. Arthritis Rheum. 2013;65:1347\u201356.","journal-title":"Arthritis Rheum"},{"key":"993_CR41","doi-asserted-by":"crossref","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","volume":"4","author":"TR Radstake","year":"2009","unstructured":"Radstake TR, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, et al. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One. 2009;4:e5903.","journal-title":"PLoS One"},{"key":"993_CR42","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3486","volume":"13","author":"ME Truchetet","year":"2011","unstructured":"Truchetet ME, Brembilla NC, Montanari E, Allanore Y, Chizzolini C. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther. 2011;13:R166.","journal-title":"Arthritis Res Ther"},{"key":"993_CR43","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","volume":"11","author":"P Gourh","year":"2009","unstructured":"Gourh P, Arnett FC, Assassi S, Tan FK, Huang M, Diekman L, et al. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Res Ther. 2009;11:R147.","journal-title":"Arthritis Res Ther"},{"key":"993_CR44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3899\/jrheum.080120","volume":"35","author":"K Komura","year":"2008","unstructured":"Komura K, Fujimoto M, Hasegawa M, Ogawa F, Hara T, Muroi E, et al. Increased serum interleukin 23 in patients with systemic sclerosis. J Rheumatol. 2008;35:120\u20135.","journal-title":"J Rheumatol"},{"key":"993_CR45","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.4049\/jimmunol.164.12.6138","volume":"164","author":"M Kuwana","year":"2000","unstructured":"Kuwana M, Medsger TA, Wright TM. Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells. J Immunol. 2000;164:6138\u201346.","journal-title":"J Immunol"},{"key":"993_CR46","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3899\/jrheum.090421","volume":"36","author":"SK Agarwal","year":"2009","unstructured":"Agarwal SK, Gourh P, Shete S, Paz G, Divecha D, Reveille JD, et al. Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis. J Rheumatol. 2009;36:2715\u201323.","journal-title":"J Rheumatol"},{"key":"993_CR47","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.23406","volume":"58","author":"F Boin","year":"2008","unstructured":"Boin F, De Fanis U, Bartlett SJ, Wigley FM, Rosen A, Casolaro V. T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease. Arthritis Rheum. 2008;58:1165\u201374.","journal-title":"Arthritis Rheum"},{"key":"993_CR48","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/art.1780400321","volume":"40","author":"MS Gruschwitz","year":"1997","unstructured":"Gruschwitz MS, Vieth G. Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage. Arthritis Rheum. 1997;40:540\u201350.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-0993-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T22:13:35Z","timestamp":1692310415000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-0993-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,4]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-0993-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,4]]},"article-number":"99"}}